Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
Biomarkers in heart failure: What’s new, tried, and true?

Harriette Van Spall, James L Januzzi

Watch time: 17m

Alessia Argirò, Juan Pablo Ochoa, Juan-Pablo Kaski, et al

Watch time: 6h 36m 27s (11 videos)

Broadcast

CV Disease in Special Populations

Guidelines & Statements
Defining Therapeutic Success in ATTR-CM

Margot K Davis, Marianna Fontana, Esther González López , et al

Watch time: 1h 1m 13s
Practice‑Changing Therapies for HFpEF/HFmrEF: SGLT2i, MRAs and Incretin Trials

Harriette Van Spall, Maja Cikes

Watch time: 22m 28s
AI in Heart Failure Care: Tools Ready for Clinical Use

Lin Yee Chen

Watch time: 5m 23s
Phenotypes to Alerts in Heart Failure

Isabella Kardys

Watch time: 7m 56s
High‑Stakes CKM Heart Failure Decisions

Robert Mentz

Watch time: 7m 27s
Optimising Heart Failure Therapy in 2026: Making GDMT Real

Stephen J Greene

Watch time: 4m 8s
Heart Failure: Mechanisms, Therapy and What We Still Get Wrong

Milton Packer

Watch time: 11m 32s
Beyond Diuretics: Splanchnic Modulation & Congestion Phenotypes in HF

Marat Fudim

Watch time: 8m 45s
Heart Failure in the Cardio-Renal-Metabolic Patient: Front-Line Decisions

Debasish Banerjee

Watch time: 9m 42s
HFA 2026: SUBCUT-HF II Subcutaneous Furosemide in HF

Ross Campbell

Watch time: 4m 6s
HFA 2026: Digitalis Glycosidesin HF: DECISION/DIGIT-HF/DIG Meta-Analysis

Kevin Damman

Watch time: 4m 10s
Imaging the Heart Failure Patient: What Should Every HF Specialist Know?

Victoria Delgado, Philippe Debonnaire

Watch time: 12m
HFA 2026: Diuretic Resistance in Heart Failure — Insights from TRANSFORM-HF

Ambarish Pandey

Watch time: 6m 3s
HFA 2026: Obesity and Natriuretic Peptides in Heart Failure — PORTHOS

Rui Baptista

Watch time: 8m 12s